153 related articles for article (PubMed ID: 15067701)
1. Effect of collapse on the stability of freeze-dried recombinant factor VIII and alpha-amylase.
Wang DQ; Hey JM; Nail SL
J Pharm Sci; 2004 May; 93(5):1253-63. PubMed ID: 15067701
[TBL] [Abstract][Full Text] [Related]
2. Development of freeze-dried biosynthetic Factor VIII: I. A case study in the optimization of formulation.
Jameel F; Tchessalov S; Bjornson E; Lu X; Besman M; Pikal M
Pharm Dev Technol; 2009; 14(6):687-97. PubMed ID: 19883259
[TBL] [Abstract][Full Text] [Related]
3. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins III: collapse during storage at elevated temperatures.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
Eur J Pharm Biopharm; 2013 Oct; 85(2):240-52. PubMed ID: 23727369
[TBL] [Abstract][Full Text] [Related]
4. Development of freeze-dried albumin-free formulation of recombinant factor VIII SQ.
Osterberg T; Fatouros A; Mikaelsson M
Pharm Res; 1997 Jul; 14(7):892-8. PubMed ID: 9244146
[TBL] [Abstract][Full Text] [Related]
5. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins I: stability after freeze-drying.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
J Pharm Sci; 2010 May; 99(5):2256-78. PubMed ID: 20039389
[TBL] [Abstract][Full Text] [Related]
6. Impact of the freeze-drying process on product appearance, residual moisture content, viability, and batch uniformity of freeze-dried bacterial cultures safeguarded at culture collections.
Peiren J; Hellemans A; De Vos P
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6239-6249. PubMed ID: 26875878
[TBL] [Abstract][Full Text] [Related]
7. Long-term stabilization of a new freeze-dried and albumin-free formulation of recombinant human interferon alpha 2b.
Ruiz L; Reyes N; Sotolongo J; Aroche K; Aldana R; Báez R; Hardy E
PDA J Pharm Sci Technol; 2006; 60(1):72-8. PubMed ID: 17089680
[TBL] [Abstract][Full Text] [Related]
8. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
9. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins, part 2: stability during storage at elevated temperatures.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
J Pharm Sci; 2012 Jul; 101(7):2288-306. PubMed ID: 22517663
[TBL] [Abstract][Full Text] [Related]
10. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
[TBL] [Abstract][Full Text] [Related]
11. Collapse temperature of freeze-dried Lactobacillus bulgaricus suspensions and protective media.
Fonseca F; Passot S; Cunin O; Marin M
Biotechnol Prog; 2004; 20(1):229-38. PubMed ID: 14763847
[TBL] [Abstract][Full Text] [Related]
12. Porosity and water activity effects on stability of crystalline β-carotene in freeze-dried solids.
Harnkarnsujarit N; Charoenrein S; Roos YH
J Food Sci; 2012 Nov; 77(11):E313-20. PubMed ID: 23094980
[TBL] [Abstract][Full Text] [Related]
13. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
Santana H; García G; Vega M; Beldarraín A; Páez R
PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
[TBL] [Abstract][Full Text] [Related]
14. Impact of residual moisture and formulation on Factor VIII and Factor V recovery in lyophilized plasma reference materials.
Hubbard A; Bevan S; Matejtschuk P
Anal Bioanal Chem; 2007 Apr; 387(7):2503-7. PubMed ID: 17072599
[TBL] [Abstract][Full Text] [Related]
15. Freeze-Drying Above the Glass Transition Temperature in Amorphous Protein Formulations While Maintaining Product Quality and Improving Process Efficiency.
Depaz RA; Pansare S; Patel SM
J Pharm Sci; 2016 Jan; 105(1):40-9. PubMed ID: 26580140
[TBL] [Abstract][Full Text] [Related]
16. Aggressive conditions during primary drying as a contemporary approach to optimise freeze-drying cycles of biopharmaceuticals.
Bjelošević M; Seljak KB; Trstenjak U; Logar M; Brus B; Ahlin Grabnar P
Eur J Pharm Sci; 2018 Sep; 122():292-302. PubMed ID: 30006178
[TBL] [Abstract][Full Text] [Related]
17. The effects of formulation variables on the stability of freeze-dried human growth hormone.
Pikal MJ; Dellerman KM; Roy ML; Riggin RM
Pharm Res; 1991 Apr; 8(4):427-36. PubMed ID: 1871037
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of a recombinant human epidermal growth factor parenteral formulation through freeze-drying.
Santana H; Sotolongo J; González Y; Hernández G; Chinea G; Gerónimo H; Amarantes O; Beldarraín A; Páez R
Biologicals; 2014 Nov; 42(6):322-33. PubMed ID: 25190208
[TBL] [Abstract][Full Text] [Related]
19. Freeze-dried snake antivenoms formulated with sorbitol, sucrose or mannitol: comparison of their stability in an accelerated test.
Herrera M; Tattini V; Pitombo RN; Gutiérrez JM; Borgognoni C; Vega-Baudrit J; Solera F; Cerdas M; Segura A; Villalta M; Vargas M; León G
Toxicon; 2014 Nov; 90():56-63. PubMed ID: 25091348
[TBL] [Abstract][Full Text] [Related]
20. Adverse effect of cake collapse on the functional integrity of freeze-dried bull spermatozoa.
Hara H; Tagiri M; Hwang IS; Takahashi M; Hirabayashi M; Hochi S
Cryobiology; 2014 Jun; 68(3):354-60. PubMed ID: 24747720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
